The desire for smaller portions and fewer junk foods is affecting what the food industry is selling us.

According to doctors, making a misstep is easier than you may think.

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These treatments can positively affect appetite, ...

GLP-1 weight-loss drugs offer promising results but come with potential risks and unknown long-term effects, emphasizing the ...

GLP‑1 weight‑loss drugs are reshaping food industry demand, but side effects, cost barriers and unclear long‑term impacts ...

GLP‑1 weight‑loss drugs are reshaping food and drink manufacturing, driving demand for portion‑smart meals, high‑protein ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

The new class of drugs has changed the game when it comes to weight loss. What are the key dietary considerations you need to ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...

Next gen weight-loss medications are powerful — but eating too little can put some patients at serious nutritional risk.

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...

GI side effects. These are common with these medications and can include nausea, diarrhea, abdominal pain, and vomiting. “Symptoms are often tolerable in younger patients; they can precipitate serious ...